Elizabeth’s Battle Against Melanoma: How Clinical Trials Changed Her Life
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
1w ago
By Mara Klecker Elizabeth Rounseville hardly knew what melanoma was when she was diagnosed in 2018 after going to see a dermatologist for a mole that was bothering her. The doctor immediately warned her that the spot on her leg didn’t look good and called a week later with the diagnosis. He directed her to a surgeon, who discovered the cancer was in her lymph nodes. “It was crazy from then on,” said Elizabeth, now 43 and living in Massachusettes. “It’s been a long, long journey.” In the years since that first diagnosis, one constant has remained: Elizabeth’s trust in her doctors and determina ..read more
Visit website
Exploring the Healing Power of Animals
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
2w ago
Ever wondered how animals can make a huge difference in people’s lives? In this podcast, we delve into the fascinating world of animal-assisted therapy and explore its incredible benefits for both physical and mental well-being. From calming anxiety to promoting social interaction, animals undeniably impact human happiness and healing. Join us as we unveil heartwarming stories and scientific insights about the transformative power of furry companions. About our guest: ⁠DR. AUBREY H. FINE⁠ Dr. Fine received his graduate degree from the University of Cincinnati in 1982 and has been on the f ..read more
Visit website
Iovance Biotherapeutics Announces Approval for TIL Therapy
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
1M ago
The Food and Drug Administration approval provides another option for advanced, refractory melanoma February 16, 2024 (Richmond, California) The FDA has approved a new immunotherapy for adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 positive, a BRAF inhibitor with or without a MEK inhibitor, called AMTAGVI™ (lifileucel), an autologous cell therapy. Harnessing the power of the body’s natural immune system received a major boost with this approval. Over the last decade, the use of immunotherapy, including immune check ..read more
Visit website
Memoir as Medicine: The Healing Power of Writing Your Messy, Imperfect, Unruly (but Gorgeously Yours) Life Story
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
1M ago
Writing has been medicine for Nancy Slonim Aronie. At nine months old, her son Dan was diagnosed with diabetes. Then, at twenty-two, he was diagnosed with multiple sclerosis. During the years she and her husband took care of Dan, and when he died at age thirty-eight, Aronie could not find the book she needed. So she wrote her memoir. In teaching memoir writing, Aronie has found that everyone has a story to tell and that telling it is important. Sharing “this is who I am, these are the things that shaped me, this is where I am now” allows a kind of magic and healing to happen. In this podcast s ..read more
Visit website
Five Things You May Not Know About Bob Marley and Acral Lentiginous Melanoma
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
1M ago
It’s an extraordinary life story: The Jamaican-born, legendary King of Reggae died at age 36 from a disease that broadly impacts people with fair complexions, not often people of color. Unfortunately, his story wasn’t fiction. Melanoma—specifically a rare subtype called acral lentiginous melanoma—tragically ended the life of the supremely talented Bob Marley. Here are five things you may not know about the life and death of Bob Marley: 1. He Tried to Fly Home to Die in May 1981 Sadly, Marley’s final days indicate that he knew every little thing was not gonna be alright. He knew he was dying. I ..read more
Visit website
Melanoma Survivor Angela Evatt: Consider a Clinical Trial for Yourself
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
1M ago
By Mara Klecker Angela Evatt grew up in Louisiana, spending her summers outside in the sun, often by the pool. At the time, she gave little thought to the sunburns she received from days spent outside or the risks of using tanning beds, which she did as a young adult. “My story really begins with my risk as a fair-skinned redhead,” Evatt said. “I never really got skin checks – no one told me about my risk.” By the end of 2019, a large mole on Angela’s back grew painful and began to bleed. Evatt was visiting family in Louisiana for the holidays, but her husband pushed her not to wait to see a d ..read more
Visit website
February is National Cancer Prevention Month
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
2M ago
Did you know that February is National Cancer Prevention Month? This annual observance is dedicated to raising awareness about cancer prevention and encouraging individuals to reduce their risk of developing cancer. Why is National Cancer Prevention Month Important? National Cancer Prevention Month was first observed in 2014 and has since been recognized every February. The goal is to educate the public about the importance of cancer prevention and early detection. According to the American Cancer Society, about 1.8 million new cancer cases are expected to be diagnosed in the United States in ..read more
Visit website
AIM at Melanoma Announces the Launch of AIM at Skin Cancer
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
2M ago
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives CONTACT: Samantha Guild President, AIM at Skin Cancer (p) 916/206-6100 (e) Info@AIMatSkinCancer.org (January 25, 2024) After two decades of providing comprehensive and accurate resources to the melanoma community, AIM at Melanoma has launched a new website called AIM at Skin Cancer. This new website will provide the same depth and breadth of resources and information to those battling nonmelanoma skin cancer. “AIM at Skin Cancer is an extremely valuable resource for all no ..read more
Visit website
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
2M ago
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool The DermaSensor device demonstrates a high rate of sensitivity in the detection of more than 200 types of skin cancers in a clinical study. January 17, 2024 – original article in Targeted Oncology Sabrina Serani   DermaSensor provides quantitative, point-of-testing identification for skin cancer, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The DermaSensor device uses artificial intelligence (AI)-powered spectroscopy to identify cellular and subcellular characteristics of lesions. The approval follows ..read more
Visit website
AIM at Melanoma Celebrating 20 Year Anniversary
AIM at Melanoma News - Melanoma research, education, awareness, and legislation
by Kathleen
2M ago
Twenty years ago, the AIM at Melanoma Foundation was established by a determined woman with a relentless drive to find the cure for melanoma while improving the lives of those it affects. Recognizing the urgent need for research after losing her 26-year-old daughter, Charlie Guild, to melanoma, Valerie Guild, the late founder of AIM at Melanoma, took it upon herself to make a difference. With dedication and passion, Val established an organization that would become a beacon of hope for patients with melanoma, and their families, caregivers, and friends. For the past two decades, this organizat ..read more
Visit website

Follow AIM at Melanoma News - Melanoma research, education, awareness, and legislation on FeedSpot

Continue with Google
Continue with Apple
OR